Structure

InChI Key NTHXOOBQLCIOLC-UHFFFAOYSA-N
Smile CC(=O)N(CC(O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I
InChI
InChI=1S/C19H26I3N3O9/c1-8(29)25(4-11(32)7-28)17-15(21)12(18(33)23-2-9(30)5-26)14(20)13(16(17)22)19(34)24-3-10(31)6-27/h9-11,26-28,30-32H,2-7H2,1H3,(H,23,33)(H,24,34)

Physicochemical Descriptors

Property Name Value
Molecular Formula C19H26I3N3O9
Molecular Weight 821.14
AlogP -1.63
Hydrogen Bond Acceptor 9.0
Hydrogen Bond Donor 8.0
Number of Rotational Bond 12.0
Polar Surface Area 199.89
Molecular species NEUTRAL
Aromatic Rings 1.0
Heavy Atoms 34.0

Pharmacology

Action Mechanism of Action Reference
None Diagnostic agent FDA

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Myocardial Ischemia 3 D017202 ClinicalTrials
Acute Kidney Injury 2 D058186 ClinicalTrials
Kidney Diseases 2 D007674 ClinicalTrials
HIV Infections 1 D015658 ClinicalTrials
Renal Insufficiency 1 D051437 ClinicalTrials
Breast Neoplasms 1 D001943 ClinicalTrials
Fabry Disease 1 D000795 ClinicalTrials

Related Entries

MCS

Side Effects from Label

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Skin and subcutaneous tissue disorders
17.33
Respiratory, thoracic and mediastinal disorders
13.01
Immune system disorders
11.59
General disorders and administration site conditions
11.11
Cardiac disorders
7.59
Nervous system disorders
7.41
Gastrointestinal disorders
7.14
Vascular disorders
6.86
Injury, poisoning and procedural complications
3.76
Musculoskeletal and connective tissue disorders
3.1
Investigations
2.73
Psychiatric disorders
2.33
Eye disorders
2.05

Cross References

Resources Reference
CAS NUMBER 66108-95-0
ChEBI 31709
ChEMBL CHEMBL1200455
DrugBank DB01362
DrugCentral 1461
EPA CompTox DTXSID6023157
FDA SRS 4419T9MX03
Human Metabolome Database HMDB0015449
PharmGKB PA450061
PubChem 3730
SureChEMBL SCHEMBL26501